In this work, we use the Estrogen Receptor (ER)-positive MCF-7 breast cancer cell line [32], [33] as a model system to demonstrate that SLIM can be used as a highly sensitive drug proliferation assay. The gene discussed is ESR1; the disease is breast carcinoma.